Testing effectiveness (Phase 2)Study completedNCT01369095
What this trial is testing
Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
Who this might be right for
Depression
Bristol-Myers Squibb 976